These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18036566)

  • 21. Novel Cinnamic Acid Derivatives as Potential PPARδ Agonists for Metabolic Syndrome: Design, Synthesis, Evaluation and Docking Studies.
    Chauhan A; Grewal AS; Pandita D; Lather V
    Curr Drug Discov Technol; 2020; 17(3):338-347. PubMed ID: 30868955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [PPAR delta and metabolic syndrome].
    Tanaka T
    Nihon Yakurigaku Zasshi; 2006 Oct; 128(4):225-30. PubMed ID: 17038785
    [No Abstract]   [Full Text] [Related]  

  • 23. Zinc finger protein 407 overexpression upregulates PPAR target gene expression and improves glucose homeostasis in mice.
    Charrier A; Wang L; Stephenson EJ; Ghanta SV; Ko CW; Croniger CM; Bridges D; Buchner DA
    Am J Physiol Endocrinol Metab; 2016 Nov; 311(5):E869-E880. PubMed ID: 27624101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender and genetic differences in bladder smooth muscle PPAR mRNA in a porcine model of the metabolic syndrome.
    Mattern HM; Lloyd PG; Sturek M; Hardin CD
    Mol Cell Biochem; 2007 Aug; 302(1-2):43-9. PubMed ID: 17318406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapeutic target for metabolic syndrome: PPARdelta.
    Takahashi S; Tanaka T; Sakai J
    Endocr J; 2007 Jun; 54(3):347-57. PubMed ID: 17409576
    [No Abstract]   [Full Text] [Related]  

  • 26. [PPARs Mediate the Regulation of Energy Metabolism By Long-Chain Fatty Acids].
    Yan Y; Wang ZB; Tang CK
    Sheng Li Ke Xue Jin Zhan; 2016 Feb; 47(1):1-6. PubMed ID: 27424398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.
    Luquet S; Gaudel C; Holst D; Lopez-Soriano J; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochim Biophys Acta; 2005 May; 1740(2):313-7. PubMed ID: 15949697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PPAR family and its relationship to metabolic syndrome].
    Zhang XY; Chen LH; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):6-12. PubMed ID: 15881336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From fat to fit.
    Ewan S
    Drug Discov Today; 2005 Jun; 10(11):744. PubMed ID: 15922929
    [No Abstract]   [Full Text] [Related]  

  • 30. Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.
    Mikami D; Kimura H; Kamiyama K; Torii K; Kasuno K; Takahashi N; Yoshida H; Iwano M
    Hypertens Res; 2014 May; 37(5):422-31. PubMed ID: 24352213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPAR Beta/Delta and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2020 May; 9(5):. PubMed ID: 32375405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
    Takada I; Makishima M
    Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
    [No Abstract]   [Full Text] [Related]  

  • 33. Constituents from Cistus salvifolius (Cistaceae) activate peroxisome proliferator-activated receptor-γ but not -δ and stimulate glucose uptake by adipocytes.
    Kühn C; Arapogianni NE; Halabalaki M; Hempel J; Hunger N; Wober J; Skaltsounis AL; Vollmer G
    Planta Med; 2011 Mar; 77(4):346-53. PubMed ID: 20922652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and voluntary exercise attenuate cardiometabolic syndrome and hepatic steatosis in ovariectomized rats fed a high-fat high-fructose diet.
    Buniam J; Chukijrungroat N; Khamphaya T; Weerachayaphorn J; Saengsirisuwan V
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E908-E921. PubMed ID: 30807216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome.
    Ramachandran U; Kumar R; Mittal A
    Mini Rev Med Chem; 2006 May; 6(5):563-73. PubMed ID: 16719831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.
    Savkur RS; Miller AR
    Expert Opin Investig Drugs; 2006 Jul; 15(7):763-78. PubMed ID: 16787140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.
    Staiger H; Haas C; Machann J; Werner R; Weisser M; Schick F; Machicao F; Stefan N; Fritsche A; Häring HU
    Diabetes; 2009 Mar; 58(3):579-89. PubMed ID: 19074989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway.
    Beyaz S; Yilmaz ÖH
    Clin Cancer Res; 2016 Dec; 22(23):5636-5641. PubMed ID: 27702819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual acting and pan-PPAR activators as potential anti-diabetic therapies.
    Heald M; Cawthorne MA
    Handb Exp Pharmacol; 2011; (203):35-51. PubMed ID: 21484566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.
    Palomer X; Barroso E; Pizarro-Delgado J; Peña L; Botteri G; Zarei M; Aguilar D; Montori-Grau M; Vázquez-Carrera M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.